Launching of a synthetic bone graft developed by the BBT

Feb 15, 2023

Nobel Biocare launches its new product, creos™ syntogain, a biocompatible synthetic porous (bone) substitute with a multidirectional interconnected porous structure for use in periodontal, oral and maxillofacial surgery. The new product is the result of many years of research by the Biomaterials, Biomechanics and Tissue Engineering (BBT) Research Group of the UPC.

Launching of a synthetic bone graft developed by the BBT — Image by vectorjuice (Freepik)

Nobel Biocare, which some months ago bought Mimetis Biomaterials, a spin-off of the Biomaterials, Biomechanics and Tissue Engineering (BBT) Research Group, has just launched its new product, creos™ syntogain, a biocompatible synthetic porous (bone) substitute.

This biomimetic bone graft substitute, with a multidirectional interconnected porous structure similar to that of human cancellous bone, is intended for use in periodontal, oral and maxillofacial surgery.

The new product, originally developed by researchers of the BBT, enables to get a bone graft with key differentiators, thanks to an advanced manufacturing process in an aqueous environment and at low temperature.